Site Search
Emerging fungal pathogens: Dr. Nancy Wengenack - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories at Mayo...
Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D. - Insights
Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing.
Tick Season Outlook: Elitza Theel, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to...
COVID-19 and Avian Flu: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the...
Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss...
Alarming Increase in Dengue Cases: Elitza Theel, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to...
Managing Compliance in Preparation for 2025 Updates - Insights
With updates expected to federal compliance guidance for laboratories in 2025, now is a great time to revisit existing guidelines and plans.
An Inside Perspective of Outreach - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by Mark Kjer, supervisor of technologist support at Mayo Clinic Laboratories....
Strategic Tech Initiatives in Lab Operations: Recipe(s) for Success - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Hereditary causes of kidney stones - Insights
Learn about our kidney stone panel, which assesses 72 genes associated with inherited conditions that can lead to stone development.
Find out how our kidney stone services identify the physical compositions of stones to help optimize care for patients with nephrolithiasis.
Urine supersaturation testing - Insights
Find out how our kidney stone testing services can predict the likely composition of stones in patients for whom stone analysis is not available.
It delivers insights that put patients on the right pathway. It drives revenue that can bolster the financial stability of the hospital. It elevates the standards of care in the communities it serves – but only if you recognize your lab’s...
Own your lab, own your future - Insights
The laboratory is the cornerstone for health systems that offer complex care. Learn how lab ownership is a key driver of patient care excellence and health system growth.
CPT codes and LOINC update: December 2024 - Insights
This will be the last CPT Codes and LOINC update. Read why.
Dr. Morice shares with Modern Healthcare how hospital-owned labs drive success - Insights
Dr. Morice highlights the crucial role of hospital-owned laboratories in enhancing patient care and hospital operations.
Why Measles Is on the Rise: Matthew Binnicker, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., professor of laboratory medicine and pathology and clinical virologist...
The Growing Crisis of Antimicrobial Resistance: Robin Patel, M.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Robin Patel, M.D., director of the Infectious Diseases Research Laboratory and co-director of the...
Avian Flu Outbreaks and New COVID-19 Variants: Matthew Binnicker, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., professor of laboratory medicine and pathology and clinical virologist...
Syphilis Testing Updates: Elitza Theel, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to...
Test helps identify elusive central nervous system pathogens: Robin Patel, M.D. - Insights
Robin Patel, M.D., explains how a new Mayo Clinic Laboratories' assay can identify central nervous system pathogens that standard tests fail to detect. Rapid, precise diagnosis is essential to preventing long-term effects from these...
Emerging and Reemerging Diseases: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss current...
Avian influenza and reflecting on three years of COVID-19: Matthew Binnicker, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo Clinic,...
Dr. Matt Binnicker sheds light on new Arcturus COVID-19 variant - Insights
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides insight on the newest COVID-19 subvariant – XBB.1.16, also known as “Arcturus.”
Circulating Strains of COVID-19: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They...
Seasonal Outlook of Respiratory Viruses: Matthew Binnicker, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo...
A team of researchers has confirmed that neutralizing monoclonal antibody (nMAb) therapies are associated with reduced risk of adverse outcomes of COVID-19 in high-risk populations. The cohort study, published in JAMA, included more than...
A New Year with Familiar Viruses: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to welcome the new...
A strong community of lab professionals: Bill Morice, M.D., Ph.D., and Susan Van Meter - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, and...
The progression of the diagnostic landscape: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to...
Five Ways to Proactively Prepare for Laboratory's Unforeseen Situations - Insights
Unexpected events in the laboratory are an inevitability of the profession. The difference in whether it is manageable or chaotic comes down to the steps taken beforehand. By proactively preparing, you can drastically reduce the number of...
Managing Operational Surprises in Real Time - Insights
While preparation is key to mitigating risk, inevitably, there are unforeseen circumstances that will impact operations. Here are four ways the outreach laboratory can swiftly manage operational surprises in real time.
How to Minimize Operational Disruptions in an Outreach Program - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton about...
Managing off-site phlebotomy: Considerations, coordination, and convenience - Insights
As the phlebotomist ventures farther from the hospital or formal outpatient setting, there are many new facets to consider. Remote phlebotomy is a patient-focused activity and can be a successful attribute for an outreach program when...
Working With Clients to Create a Smooth Testing Journey - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton for the...
Preparing for Changes in Laboratory Regulations - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with Shannon Bennett, director of Quality and Regulatory Affairs for the Department...
Expanding Reach Through Home Phlebotomy - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with Camille Jewell, outpatient laboratory service technician at Mayo Clinic. They...
Dangerous Goods Training Has Moved - Insights
Update your bookmark! Dangerous Goods can now be found at https://news.mayocliniclabs.com/dangerous-goods-training/
Exploratory testing - Insights
Mayo Clinic Laboratories’ whole exome and whole genome sequencing assays provide in-depth interrogation of all the genes in the human genome, offering individualized insights for optimal outcomes.
Learn more about how immunology testing at Mayo Clinic Laboratories can reveal genetic associations to disorders that impact the immune system.
Focused Pharmacogenomics Panel [Test in Focus] - Insights
Ann Moyer, M.D., Ph.D., explains Mayo Clinic Labs’ new focused pharmacogenomics panel, a real-time, PCR-based testing approach that assesses 10 genes known for their drug-gene associations, to provide guidance on medication selection for...
Comprehensive panels - Insights
Check out Mayo Clinic Laboratories’ comprehensive pharmacogenomic panels, which identify genetic variations associated with treatment response.
Frequently asked questions - Insights
Check out the answers to the most frequently asked questions about pharmacogenomic testing at Mayo Clinic Laboratories.